Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)

Norberto Perico, Giuseppe Remuzzi, Matthew D. Griffin, Paul Cockwell, Alexander P. Maxwell, Federica Casiraghi, Nadia Rubis, Tobia Peracchi, Alessandro Villa, Marta Todeschini, Fabiola Carrara, Bernadette A. Magee, Piero L. Ruggenenti, Stefano Rota, Laura Cappelletti, Veronica McInerney, Tomás P. Griffin, Md Nahidul Islam, Martino Introna, Olga Pedrini, Josée Golay, Andrew A. Finnerty, Jon Smythe, Willem E. Fibbe, Stephen J. Elliman, Timothy O'Brien, Unknown

Open source

DOI: 10.1681/asn.0000000000000189
Published: 2023-08-10
Container: Journal of the American Society of Nephrology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1681/asn.0000000000000189,
  title = {Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)},
  author = {Norberto Perico and Giuseppe Remuzzi and Matthew D. Griffin and Paul Cockwell and Alexander P. Maxwell and Federica Casiraghi and Nadia Rubis and Tobia Peracchi and Alessandro Villa and Marta Todeschini and Fabiola Carrara and Bernadette A. Magee and Piero L. Ruggenenti and Stefano Rota and Laura Cappelletti and Veronica McInerney and Tomás P. Griffin and Md Nahidul Islam and Martino Introna and Olga Pedrini and Josée Golay and Andrew A. Finnerty and Jon Smythe and Willem E. Fibbe and Stephen J. Elliman and Timothy O'Brien and Unknown},
  year = {2023},
  journal = {Journal of the American Society of Nephrology},
  doi = {10.1681/asn.0000000000000189},
  url = {https://doi.org/10.1681/asn.0000000000000189}
}

RIS

TY  - JOUR
TI  - Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
AU  - Norberto Perico
AU  - Giuseppe Remuzzi
AU  - Matthew D. Griffin
AU  - Paul Cockwell
AU  - Alexander P. Maxwell
AU  - Federica Casiraghi
AU  - Nadia Rubis
AU  - Tobia Peracchi
AU  - Alessandro Villa
AU  - Marta Todeschini
AU  - Fabiola Carrara
AU  - Bernadette A. Magee
AU  - Piero L. Ruggenenti
AU  - Stefano Rota
AU  - Laura Cappelletti
AU  - Veronica McInerney
AU  - Tomás P. Griffin
AU  - Md Nahidul Islam
AU  - Martino Introna
AU  - Olga Pedrini
AU  - Josée Golay
AU  - Andrew A. Finnerty
AU  - Jon Smythe
AU  - Willem E. Fibbe
AU  - Stephen J. Elliman
AU  - Timothy O'Brien
AU  - Unknown
PY  - 2023
JO  - Journal of the American Society of Nephrology
DO  - 10.1681/asn.0000000000000189
UR  - https://doi.org/10.1681/asn.0000000000000189
ER  -

APA

Perico, N., Remuzzi, G., Griffin, M. D., Cockwell, P., Maxwell, A. P., Casiraghi, F., Rubis, N., Peracchi, T., Villa, A., Todeschini, M., Carrara, F., Magee, B. A., Ruggenenti, P. L., Rota, S., Cappelletti, L., McInerney, V., Griffin, T. P., Islam, M. N., Introna, M., Pedrini, O., Golay, J., Finnerty, A. A., Smythe, J., Fibbe, W. E., Elliman, S. J., O'Brien, T., & Unknown (2023). Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM). Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000000000000189

Source records

crossref · retrieved 2026-09-26T17:25:05.867Z